Home

ARNOLD L ORONSKY

CIK 1207833 · last filed 2020-10-02

ARNOLD L ORONSKY is a corporate insider who has filed 55 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for PMVP, was dated Oct 2, 2020. Across all open-market trades the lifetime net is −$575.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$14.35M

Companies

12

Total Filings

55

Lifetime Open-Market Net

-$575.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PMVP Director 6,469,911 $1.24 $8.02M $1.99M 2 2020-10-02
KalVista Pharmaceuticals, Inc. (KALV) Delisted Director 388,766 $27.00 $10.50M $1.00M 6 2020-10-02
DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted Director 37,506 $15.50 $581.3K $600.0K 18 2020-05-29
Eiger BioPharmaceuticals, Inc. (EIGR) Delisted 10%+ Owner 45,411 $1.73 $78.3K -$17.17M 1 2018-10-22
TESARO, Inc. (TSRO) Delisted Director 3,817 — — $10.73M 10 2018-08-09
APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Director 1,404,515 $0.39 $552.8K $0 4 2017-04-26
MGNX Director 1,708,716 $3.70 $6.32M -$7.30M 3 2014-02-18
Marketo, Inc. (MKTO) Delisted 10%+ Owner 7,663,756 — — -$637.37M 1 2013-09-18
Trius Therapeutics Inc (TSRX) Delisted 3,548,643 — — $61.37M 1 2010-08-10
MBRX Director 1,536 $2.12 $3.3K $2.32M 4 2009-06-24
ANESIVA, INC. (ANSV) Delisted Director 132,388 — — $8.00M 3 2008-05-12
ReShape Weightloss Inc. (ETRM) Delisted 10%+ Owner 257,794 — — $0 1 2007-11-21

Recent Filings

55 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-10-02 PMVP Mixed +6,469,911 $1000.0K EDGAR
2020-10-02 KalVista Pharmaceuticals, Inc. (KALV) Delisted Grant (A) — $0 EDGAR
2020-09-29 PMVP Mixed +6,469,356 $990.0K EDGAR
2020-05-29 DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted Grant (A) — $0 EDGAR
2019-10-03 KalVista Pharmaceuticals, Inc. (KALV) Delisted Grant (A) — $0 EDGAR
2019-05-31 DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted Grant (A) — $0 EDGAR
2018-10-22 Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Sell (S) −1,423,590 -$17.17M EDGAR
2018-10-05 KalVista Pharmaceuticals, Inc. (KALV) Delisted Grant (A) — $0 EDGAR
2018-09-12 KalVista Pharmaceuticals, Inc. (KALV) Delisted Buy (P) +58,824 $1.00M EDGAR
2018-08-09 TESARO, Inc. (TSRO) Delisted Mixed — -$267.7K EDGAR
Showing 1–10 of 55
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.